Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-115142
Filing Date
2022-04-22
Accepted
2022-04-22 16:12:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d253068ddefa14a.htm DEFA14A 14288
2 GRAPHIC g253068g01a01.jpg GRAPHIC 289125
3 GRAPHIC g253068g02a33.jpg GRAPHIC 111654
  Complete submission text file 0001193125-22-115142.txt   566766
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40315 | Film No.: 22845648
SIC: 2834 Pharmaceutical Preparations